FluoSphera developed scalable and transferable human-relevant 3D tissue technologies to improve drug efficacy and safety prediction, from HTS screening and DMPK-Tox to biomarker discovery.
Our proprietary platform combines Pleiad, a portfolio of ready-to-use 3D human tissues, with color-coded multi-tissue systems that recreate systemic biology in a practical, standardized format. Designed for automation and high-content analysis, the platform can be transferred and deployed across laboratories.